Who Owns Whom

pharmaceutical industry south africa

The Pharmaceutical Industry in South Africa 2023

Gary Phillips | South Africa | 23 August 2023

The Pharmaceutical Industry in South Africa 2022

Carole Veitch | South Africa | 08 March 2022

The Pharmaceutical Industry in South Africa 2020

Carole Veitch | South Africa | 11 December 2020

The Pharmaceutical Industry in South Africa 2019

Ebhrahim Khalil | South Africa | 05 April 2019

The Pharmaceutical Industry in South Africa 2017

Ebrahim-Khalil Hassen | South Africa | 08 December 2017

The Pharmaceutical Industry in South Africa 2016

Ebrahim-Khalil Hassen | South Africa | 12 September 2016

The Pharmaceutical Industry in South Africa 2014

Amanda van der Westhuizen | South Africa | 30 May 2014

Enquire about this report

Report Coverage

This report on the pharmaceutical industry in South Africa provides comprehensive information on the manufacturing, wholesale and retail subsectors, price regulation, medical cannabis, market shares, notable multinational and local players and corporate actions. There are profiles of 128 companies including local dominant players Aspen Pharmacare and Adcock Ingram, multinationals such as Bayer, GlaxoSmithKline and Pfizer and retailers Clicks and Dis-Chem and other players such as Nativa.

Introduction

• More than 80% of South African pharmaceutical manufacturing and distribution revenue is from the private sector.
• State purchases of pharmaceuticals are declining, and manufacturers’ margins are under pressure due to low regulated price increases for scheduled pharmaceuticals in a high inflation environment.
• In the retail sector Clicks and Dis-Chem have wholesale volume advantages and an ever-increasing footprint.
• Consumer spending patterns have forced consolidation in the retail sector, the growth of private label sales, growth in convenience formats, and diversification into new services and products.
• There has been a flurry of investments in localising vaccine raw material and finished dose manufacturing, although the sustainability of these initiatives is far from secure.

Trends

• A shift from reactive medicine to preventative healthcare resulting in demand for immunity-building vitamins, tonics, minerals and supplements.
• Focus on research and development, particularly drugs and therapies targeting COVID-19, HIV/Aids, TB, malaria, cancer, and chronic diseases.
• Growing pressure on pharmaceutical companies to improve access to healthcare by making medicines more affordable.
• Increased focus on localisation, including local sourcing of inputs and the development of local manufacturing capacity.
• Recovery of demand as elective surgery and procedures and illnesses such as flu return to pre-pandemic patterns.
• Small community pharmacies are finding it difficult to compete with large retail businesses.

Opportunities

• Cannabis cultivation, processing and medical product manufacturing.
• Rapid growth in generic sales making medicine more affordable.
• Strong R&D and advanced manufacturing capabilities may attract investment-.

Challenges

• Growing concentration of wholesale and retail pharmacy supply.
• Low regulated medicine price increases in the context of high international inflation.
• Poor economic growth constraining consumer spending on healthcare.
• Reduced government budgets for medicines restricting local opportunities in the face of cheaper international competition.
• South Africa’s dependence on imported active ingredients.
• Sustaining local vaccine manufacturing in the face of declining demand.

Outlook

• The pharmaceutical industry is well developed and supported by strong R&D and advanced manufacturing capabilities, including biotechnology manufacturing facilities.
• The Department of Health’s affordable medicines programme has been instrumental in lowering scheduled pharmaceutical prices, particularly in the public sector.
• Investments in vaccine manufacture have begun to address South Africa’s exposure to vulnerabilities and dependence on active pharmaceutical ingredient and vaccine imports.
• These investments have strengthened South Africa’s position as the hub for sub-Saharan African pharmaceutical research, development, and supply.
• However, vaccine demand has dropped and doses are being donated to African countries.
• Margin pressure is expected to grow as the economy remains poor and restraints on consumer spending intensify.
• The implementation of the National Health Insurance is likely to put further pressure on manufacturers and wholesalers to reduce medicine prices.

Read More..
The Pharmaceutical Industry in South Africa 2023

Full Report

R 20 000.00(ZAR) estimated $1044.05 (USD)*

Industry Landscape

R 14 000.00(ZAR) estimated $ 730.83 (USD)*

Historical Reports

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $339.32 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

Table of Contents

[ Close ]
PAGE
1. INTRODUCTION 1
2. DESCRIPTION OF THE INDUSTRY 1
2.1. Industry Value Chain 9
2.2. Geographic Position 10
2.3. Size of the Industry 11
3. LOCAL 17
3.1. State of the Industry 17
3.2. Key Trends 22
3.3. Key Issues 23
3.4. Notable Players 24
3.5. Trade 34
3.6. Corporate Actions 36
3.7. Regulations 38
3.8. Enterprise Development and Social Development 43
4. AFRICA 45
5. INTERNATIONAL 50
6. INFLUENCING FACTORS 57
6.1. Unforeseen Events 57
6.2. Economic Environment 58
6.3. Labour 60
6.4. Environmental Issues 62
6.5. Technology, R&D, Innovation 63
6.6. Government Support 65
6.7. Input Costs 67
6.8. Drug Abuse and Other Health Concerns 68
7. COMPETITIVE ENVIRONMENT 68
7.1. Competition 68
7.2. Ownership Structure of the Industry 70
7.3. Barriers to Entry 70
8. INDUSTRY SUMMARY 71
9. OUTLOOK 72
10. INDUSTRY ASSOCIATIONS 72
11. REFERENCES 73
11.1. Publications 73
11.2. Websites 74
APPENDIX 1 75
Summary of Notable Players 75
COMPANY PROFILES 89
Abbott Laboratories South Africa (Pty) Ltd 89
Acino Healthcare Group (Pty) Ltd 91
Adcock Ingram Holdings Ltd 93
African Medicines (Pty) Ltd 98
Afrigen Biologics (Pty) Ltd 100
Afriplex (Pty) Ltd 102
AIM Africa 105
Alpha Pharm (Pty) Ltd 107
Amka Products (Pty) Ltd 109
Amway South Africa (Pty) Ltd 112
Arrie Nel Pharmacy Group (Pty) Ltd 114
Ascendis Health Ltd 116
Aspen Pharmacare Holdings Ltd 121
Astellas Pharma (Pty) Ltd 127
AstraZeneca Pharmaceuticals (Pty) Ltd 129
Aurobindo Pharma (Pty) Ltd 131
Austell Pharmaceuticals (Pty) Ltd 133
B Braun Medical (Pty) Ltd 135
Barrs Pharmaceuticals Industries (Pty) Ltd 138
Baxter Healthcare South Africa (Pty) Ltd 140
Bayer (Pty) Ltd 142
Becton Dickinson (Pty) Ltd 145
Bio Earth Manufacturing (Pty) Ltd 147
Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd (The) 149
Bitek Industries (Pty) Ltd 151
California Pharmaceuticals (Pty) Ltd 153
Caprichem (Pty) Ltd 155
Chemical Convertors (Pty) Ltd 157
Chemtron Holdings (Pty) Ltd 158
Cilo Cybin Pharmaceutical (Pty) Ltd 160
Cipla Medpro South Africa (Pty) Ltd 162
Columbia Pharmaceuticals (Pty) Ltd 165
CoMED Health (Pty) Ltd 167
Deon Schoeman CC 169
Dis-Chem Pharmacies Ltd 172
Dr Reddy's Laboratories (Pty) Ltd 184
DSV Solutions (Pty) Ltd 186
Dynachem (Pty) Ltd 188
Ecolab (Pty) Ltd 190
Eli Lilly (S A) (Pty) Ltd 192
Evohealth (Pty) Ltd 194
Felbridge (Pty) Ltd 196
Ferring (Pty) Ltd 198
Forever Living Products South Africa (Pty) Ltd 200
Fresenius Kabi Manufacturing SA (Pty) Ltd 203
Fresenius Kabi South Africa (Pty) Ltd 205
G M Pharmaceuticals (Pty) Ltd 208
GlaxoSmithKline South Africa (Pty) Ltd 210
Glenmark Pharmaceuticals South Africa (Pty) Ltd 213
Goodleaf Company (Pty) Ltd (The) 215
Gulf Drug Company (Pty) Ltd 217
H H Durrheim (Pty) Ltd 219
Herba Zone (Pty) Ltd 221
Herbalife International South Africa Ltd 223
Hersol Manufacturing Laboratories (Pty) Ltd 225
Hymed (Pty) Ltd 227
IMBC Investment (Pty) Ltd 229
iMvula Healthcare Logistics (Pty) Ltd 231
Infection Protection Products (Pty) Ltd 233
Ingelheim Pharmaceuticals (Pty) Ltd 235
Iszipharm Pharmaceutical Distributors (Pty) Ltd 237
Joe Soap CC 239
Johnson and Johnson (Pty) Ltd 241
Kellogg Company of South Africa (Pty) Ltd 243
Kevali Chemical Group (Pty) Ltd 245
Lakato (Pty) Ltd 247
Leaf Botanicals (Pty) Ltd 249
MedCan (Pty) Ltd 250
Medichem (Pty) Ltd 251
Mega Magic CC 252
Merck (Pty) Ltd 254
MSD (Pty) Ltd 256
National Bioproducts Institute NPC 258
Nativa (Pty) Ltd 260
NeoLife International (Pty) Ltd 262
Nestle (South Africa) (Pty) Ltd 264
Netcare Pharmacies (Pty) Ltd 268
Netcare Pharmacies 2 (Pty) Ltd 270
New Clicks South Africa (Pty) Ltd 272
Nkunzi Pharmaceuticals (Pty) Ltd 276
Novartis South Africa (Pty) Ltd 278
Omnia Holdings Ltd 280
Organon South Africa (Pty) Ltd 286
P and G South African Trading (Pty) Ltd 288
Parceval (Pty) Ltd 290
Pfizer Laboratories (Pty) Ltd 292
Pharma Dynamics (Pty) Ltd 295
Pharmaceutical Enterprises (Pty) Ltd 297
Pharmacy Direct (Pty) Ltd 299
Pharmacyweb Holdings (Pty) Ltd 301
PharmaForce (Pty) Ltd 302
Pharmed Pharmaceuticals (Pty) Ltd 304
Pick n Pay Stores Ltd 306
Platchem (Pty) Ltd 311
Prime Cleaning Suppliers (Pty) Ltd 312
Ranbaxy (S A) (Pty) Ltd 314
Ranbaxy Pharmaceuticals (Pty) Ltd 316
Reckitt Benckiser Pharmaceuticals (Pty) Ltd 318
Releaf Pharmaceuticals (Pty) Ltd 320
Richbay Chemicals (Pty) Ltd 322
Roche Products (Pty) Ltd 324
S A F I C (Pty) Ltd 327
S A Natural Products (Pty) Ltd 329
S Buys (Pty) Ltd 331
Safarmex (Pty) Ltd 334
Safety Chemicals (Pty) Ltd 336
Sandoz South Africa (Pty) Ltd 337
Sanofi Industries South Africa (Pty) Ltd 339
Sanofi-Aventis South Africa (Pty) Ltd 341
Shoprite Holdings Ltd 344
Solgar South Africa (Pty) Ltd 349
Sonke Pharmaceuticals (Pty) Ltd 351
South African Nuclear Energy Corporation SOC Ltd (The) 353
SPAR Group Ltd (The) 357
Specialised Maintenance Products (Pty) Ltd 362
Specpharm Holdings (Pty) Ltd 363
Spectank (Pty) Ltd 365
Tevo (Pty) Ltd 368
Tiger Brands Ltd 370
Topmed Health Care Distributors (Pty) Ltd 375
Touchless Germ Control Western Cape CC 377
Transpharm (Pty) Ltd 378
Unilever South Africa (Pty) Ltd 380
Viatris South Africa (Pty) Ltd 383
Vital Health Foods (Pty) Ltd 385
Waco Africa (Pty) Ltd 387
Wellness Warehouse (Pty) Ltd 391
Woolworths Holdings Ltd 395

Report Coverage

This report focuses on the pharmaceutical industry in South Africa including manufacture, retail and wholesale trade in pharmaceuticals and alternative health products, such as medicinal cannabis. The report includes information on the state and size of the industry, notable players in each subsector, developments, corporate actions, regulations and other influencing factors. There are profiles of 129 companies including international companies Cipla, Novartis, Johnson & Johnson and Pfizer, local companies including Aspen and Adcock Ingram, retailers Clicks and Dis-Chem, and cannabis companies such as Goodleaf.

Introduction

The importance of the pharmaceutical industry has been amplified by the COVID-19 pandemic and the resulting global health crisis. The sector, which generated total sales revenue of around R60.4bn in 2021, has been designated as a strategic industry as it produces and supplies essential products. South Africa has the world’s largest antiretroviral (ARV) programme and is one of the major producers of radiopharmaceuticals . With the ongoing development of local manufacturing capacity and capabilities, local pharmaceutical companies are set to play a pivotal role in the production and supply of COVID-19 vaccines and other medicines for the domestic market and the rest of Africa. This report also examines the wholesale and retail trade in pharmaceuticals and alternative health products, such as medicinal cannabis. In 2021, government unveiled a cannabis master plan that aims to expand the country’s nascent cannabis industry, attract foreign investment and create up to 25,000 jobs. While cannabis is widely touted as a panacea, medical scientists caution that there is still a lack of reliable evidence to support claims about its medical efficacy.

Strengths

• South Africa has the largest antiretroviral (ARV) treatment programme in the world and almost half of the people infected with HIV/Aids in South Africa are on ARVs.
• South Africa is one of the world’s largest producers of radiopharmaceuticals.
• South Africa is the only Southern African Development Community member country that complies with the World Health Organisation’s Good Manufacturing Practice standards.
• The industry is supported by strong research and development capabilities and advanced manufacturing capabilities, including biotechnology manufacturing facilities.
• The presence of several of the world’s largest pharmaceutical companies supports research and product development.

Weaknesses

• Although pharmaceuticals are strictly regulated, over-the-counter medications and prescription drugs are widely misused and abused.
• Inadequate quality control of CBD products, hand sanitisers and other hygiene products.
• The cost of medicinal products, particularly newly developed treatments such as cell and gene therapies, is high.
• There are around 30 pharmacists per 100,000 people, well below the global benchmark of 50 per 100,000.
• There is an overreliance on imported active pharmaceutical ingredients and certain finished medicinal products.

Opportunities

• Advances in 3D printing have made the production of small batches of tablets viable.
• As the Department of Health expands its chronic medication delivery and collection services programme, greater collaboration between the public health sector and pharmacies is anticipated.
• Government has identified the pharmaceutical industry as a strategic sector and it supports the procurement of locally-manufactured products.
• National Health Insurance offers opportunities for private sector community
• Participation of retail pharmacies in the national vaccination programme.
• pharmacies to provide primary care services to public health patients.
• Strong demand for home delivery services is driving the expansion of courier pharmacy networks.
• The development and manufacture of active pharmaceutical ingredients.
• The development of traditional/indigenous medicines.
• The development, produc

Threats

• Climate-change related shocks.
• Counterfeit medication and substandard products pose health risks.
• Further reputational damage resulting from the misuse/abuse of prescription drugs.
• Global supply chain disruptions.
• Misinformation spread via social media and other channels about vaccinations and unproven remedies.
• New COVID-19 variants and the outbreak of other pandemics.
• Social unrest.
• Sustained economic pressures could result in funding constraints.
• The emergence of drug-resistant super bugs.

Outlook

The pandemic has brought into sharp focus the critical need for access to vaccines and affordable medicines. The gridlocked global supply chain has highlighted the risks associated with South Africa’s over-reliance on imports for active pharmaceutical ingredients and essential drugs. While stakeholders have welcomed initiatives to boost domestic manufacturing capacity and capabilities, they say that South Africa needs to reduce its dependency on imported inputs. With free trade under the African Continental Free Trade Area Agreement underway, role players anticipate that South African pharmaceutical manufacturers will perform an increasingly important role in the provision of vaccines and other pharmaceutical products to the rest of Africa. In the retail space, analysts foresee continued expansion of ecommerce and other dispensing channels, such as pharmaceutical vending machines. Stakeholders say that the collaboration of private retail pharmacies with the Department of Health on the COVID-19 vaccination programme has proved highly successful and paves the way for future partnerships between the public and private sectors. While the pandemic presents opportunities for companies in the pharmaceutical value chain, analysts expect the operating environment to remain challenging over the medium-term. Analysts predict that the local medical cannabis industry will expand rapidly over the next five years. While some smaller cannabis businesses have reservations about large pharmaceutical companies dominating the market, others say that the industry has been given a “shot in the arm” by government’s cannabis master plan.

Read More..
The Pharmaceutical Industry in South Africa 2022

Full Report

R 6 500.00(ZAR) estimated $339.32 (USD)*

Industry Landscape

R 4 550.00(ZAR) estimated $ 237.52 (USD)*

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 20 000.00(ZAR) estimated $1044.05 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

Table of Contents

[ Close ]
PAGE
1. INTRODUCTION 1
2. DESCRIPTION OF THE INDUSTRY 1
2.1. Industry Value Chain 10
2.2. Geographic Position 11
2.4. Key Success Factors and Pain Points 18
3. LOCAL 19
3.1. Key Trends 22
3.2. Notable Players 24
3.3. Trade 27
3.4. Corporate Actions 32
3.5. Regulations 34
3.6. Enterprise Development and Social Economic Development 40
4. AFRICA 42
5. INTERNATIONAL 49
6. INFLUENCING FACTORS 56
6.1. COVID -19 56
6.2. Economic Environment 61
6.3. Labour 62
6.4. Environmental Issues 66
6.5. Technology, Research and Development (R&D) and Innovation 67
6.6. Government Support 69
6.7. Drug Abuse and Other Health Concerns 71
7. COMPETITIVE ENVIRONMENT 73
7.1. Competition 73
7.2. Ownership Structure of the Industry 74
7.3. Barriers to Entry 75
8. SWOT ANALYSIS 75
9. OUTLOOK 77
10. INDUSTRY ASSOCIATIONS 78
11. REFERENCES 79
11.1. Publications 79
11.2. Websites 80
APPENDICES 82
Appendix 1 - Summary of Notable Players 82
COMPANY PROFILES 95
Abbott Laboratories South Africa (Pty) Ltd 95
Acino Healthcare Group (Pty) Ltd 97
Adcock Ingram Holdings Ltd 100
African Medicines (Pty) Ltd 105
Afrigen Biologics (Pty) Ltd 107
Afriplex (Pty) Ltd 109
AIM Africa 112
Alpha Pharm (Pty) Ltd 114
Amka Products (Pty) Ltd 117
Amway South Africa (Pty) Ltd 120
Arrie Nel Pharmacy Group (Pty) Ltd 122
Ascendis Health Ltd 124
Aspen Pharmacare Holdings Ltd 130
Astellas Pharma (Pty) Ltd 136
AstraZeneca Pharmaceuticals (Pty) Ltd 138
Aurobindo Pharma (Pty) Ltd 140
Austell Pharmaceuticals (Pty) Ltd 142
B Braun Medical (Pty) Ltd 144
Barrs Pharmaceuticals Industries (Pty) Ltd 147
Baxter Healthcare South Africa (Pty) Ltd 149
Bayer (Pty) Ltd 151
Becton Dickinson (Pty) Ltd 154
Bio Earth Manufacturing (Pty) Ltd 156
Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd (The) 158
Bitek Industries (Pty) Ltd 160
California Pharmaceuticals (Pty) Ltd 162
Caprichem (Pty) Ltd 164
Chemical Convertors (Pty) Ltd 167
Chemtron Holdings (Pty) Ltd 168
Cilo Cybin Pharmaceutical (Pty) Ltd 170
Cipla Medpro South Africa (Pty) Ltd 172
Columbia Pharmaceuticals (Pty) Ltd 176
CoMED Health (Pty) Ltd 178
Deon Schoeman CC 180
Dis-Chem Pharmacies Ltd 182
Dr Reddy's Laboratories (Pty) Ltd 193
DSV Healthcare (Pty) Ltd 195
Dynachem (Pty) Ltd 197
Ecolab (Pty) Ltd 199
Eli Lilly (S A) (Pty) Ltd 201
Evohealth (Pty) Ltd 203
Felbridge (Pty) Ltd 205
Ferring (Pty) Ltd 207
Forever Living Products South Africa (Pty) Ltd 209
Fresenius Kabi Manufacturing SA (Pty) Ltd 212
Fresenius Kabi South Africa (Pty) Ltd 214
G M Pharmaceuticals (Pty) Ltd 217
GlaxoSmithKline South Africa (Pty) Ltd 219
Glenmark Pharmaceuticals South Africa (Pty) Ltd 222
Goodleaf Company (Pty) Ltd (The) 224
Gulf Drug Company (Pty) Ltd 226
H H Durrheim (Pty) Ltd 228
Herba Zone (Pty) Ltd 230
Herbalife International South Africa Ltd 232
Hersol Manufacturing Laboratories (Pty) Ltd 234
Hymed (Pty) Ltd 236
IMBC Investment (Pty) Ltd 238
iMvula Healthcare Logistics (Pty) Ltd 240
Infection Protection Products (Pty) Ltd 243
Ingelheim Pharmaceuticals (Pty) Ltd 245
Iszipharm Pharmaceutical Distributors (Pty) Ltd 247
Joe Soap CC 249
Johnson and Johnson (Pty) Ltd 251
Kellogg Company of South Africa (Pty) Ltd 253
Kevali Chemical Group (Pty) Ltd 255
Lakato (Pty) Ltd 257
Leaf Botanicals (Pty) Ltd 259
MedCan (Pty) Ltd 260
Medichem (Pty) Ltd 261
Mega Magic CC 263
Merck (Pty) Ltd 265
MSD (Pty) Ltd 267
National Bioproducts Institute NPC 269
Nativa (Pty) Ltd 271
NeoLife International (Pty) Ltd 273
Nestle (South Africa) (Pty) Ltd 275
Netcare Pharmacies (Pty) Ltd 279
Netcare Pharmacies 2 (Pty) Ltd 281
New Clicks South Africa (Pty) Ltd 283
Nkunzi Pharmaceuticals (Pty) Ltd 286
Novartis South Africa (Pty) Ltd 288
Nutritional Holdings Ltd 291
Omnia Holdings Ltd 295
Organon South Africa (Pty) Ltd 300
P and G South African Trading (Pty) Ltd 302
Parceval (Pty) Ltd 304
Pfizer Laboratories (Pty) Ltd 306
Pharma Dynamics (Pty) Ltd 309
Pharmaceutical Enterprises (Pty) Ltd 311
Pharmacy Direct (Pty) Ltd 313
Pharmacyweb Holdings (Pty) Ltd 315
PharmaForce (Pty) Ltd 316
Pharmed Pharmaceuticals (Pty) Ltd 318
Pick n Pay Stores Ltd 321
Platchem (Pty) Ltd 326
Prime Cleaning Suppliers (Pty) Ltd 328
Ranbaxy (S A) (Pty) Ltd 330
Ranbaxy Pharmaceuticals (Pty) Ltd 332
Reckitt Benckiser Pharmaceuticals (Pty) Ltd 334
Releaf Pharmaceuticals (Pty) Ltd 336
Richbay Chemicals (Pty) Ltd 338
Roche Products (Pty) Ltd 341
S A F I C (Pty) Ltd 344
S A Natural Products (Pty) Ltd 346
S Buys (Pty) Ltd 348
Safarmex (Pty) Ltd 351
Safety Chemicals (Pty) Ltd 353
Sandoz South Africa (Pty) Ltd 355
Sanofi Industries South Africa (Pty) Ltd 357
Sanofi-Aventis South Africa (Pty) Ltd 359
Shoprite Holdings Ltd 362
Solgar South Africa (Pty) Ltd 368
Sonke Pharmaceuticals (Pty) Ltd 370
South African Nuclear Energy Corporation Ltd (The) 372
SPAR Group Ltd (The) 376
Specialised Maintenance Products (Pty) Ltd 382
Specpharm Holdings (Pty) Ltd 383
Spectank (Pty) Ltd 385
Tevo (Pty) Ltd 387
Tiger Brands Ltd 389
Topmed Health Care Distributors (Pty) Ltd 394
Touchless Germ Control Western Cape CC 396
Transpharm (Pty) Ltd 397
Unilever South Africa (Pty) Ltd 399
Vital Health Foods (Pty) Ltd 403
Waco Africa (Pty) Ltd 405
Wellness Warehouse (Pty) Ltd 409
Woolworths Holdings Ltd 413
Xixia Pharmaceuticals (Pty) Ltd 417

Report Coverage

This report focuses on the manufacture of pharmaceuticals in South Africa and includes the wholesale and retail trade in pharmaceutical products. It includes information on the state and size of the sector and influencing factors including the response to coronavirus, regulation, research and development and competition. There are profiles of 122 companies including international companies operating in South Africa such as Cipla, Sanofi and Novartis, major local manufacturers such as Aspen and Adcock Ingram and retailers including Clicks and Dis-Chem. Other profiles include state-owned South African Nuclear Energy Corporation, whose subsidiary NTP Radioisotopes is one of the world’s largest producers of medical radioisotopes and radioisotope-based diagnostic imaging and therapy products, and Alpha Pharm pharmacies, the largest group of independent community pharmacies in South Africa.

Introduction

This report focuses on the manufacture of pharmaceuticals in South Africa and examines the wholesale and retail trade in pharmaceutical products. The domestic pharmaceutical market, which generated total revenue of approximately R56.4bn in 2019, is a supplier of essential products that improve health and save lives and has been identified by government as a strategic sector. South Africa’s antiretroviral (ARV) programme is the largest of its kind globally and the country is one of the world’s major producers of radiopharmaceuticals0F . The importance of the pharmaceutical sector has been amplified by the coronavirus pandemic, which has created an unprecedented global health crisis. South Africa produces the steroid dexamethasone, which has proved to be a game-changer in the treatment of severe coronavirus cases, and local researchers continue to play a key role in coronavirus vaccine trials. In the absence of a safe and effective vaccine, hand sanitisers and other hygiene products remain in high demand and the market continues to be flooded with products supplied by non-specialist companies.

Strengths

• About 70% of pharmaceutical products consumed in South Africa are locally produced.
• South Africa is one of the world’s largest producers of radiopharmaceuticals.
• South Africa’s HIV/Aids antiretroviral (ARV) programme is the largest of its kind in the world.
• The presence of several of the world’s largest pharmaceutical companies facilitates knowledge sharing and supports research and product development.
• The South African pharmaceutical industry is well developed and complies with World Health Organisation production standards.
• There is a high standard of research and development.

Weaknesses

• Although pharmaceuticals are strictly regulated, over-the-counter medications and prescription drugs are widely misused and abused.
• Quality control relating to hand sanitisers and other hygiene products.
• The cost of medicinal products, particularly newly developed treatments such as cell and gene therapies, is high.
• There are around 26 pharmacists per 100,000 people, well below the global benchmark of 50 per 100,000.
• There is an overreliance on imported active pharmaceutical ingredients.

Opportunities

• Advances in 3D printing have made the production of small batches of tablets viable.
• As the Department of Health expands its chronic medication delivery and collection services programme, greater collaboration between it and pharmacies is anticipated.
• Government has identified the pharmaceutical industry as a strategic sector and it supports the procurement of locally manufactured products.
• Strong demand for home delivery services is driving the expansion of courier pharmacy networks.
• The development of bio-based medicinal products using locally sourced plant-based ingredients.
• The development, production and supply of health products containing cannabidiol.
• The National Health Insurance offers opportunities for private sector community pharmacies to provide primary care services to public health patients.
• The supply of complementary (alternative) healthcare products via online and mobile retail

Threats

• Climate change-related shocks.
• Counterfeit medication and substandard sanitising products pose a threat to public health and safety.
• Economic pressures could result in funding constraints.
• Further reputational damage resulting from the misuse/abuse of prescription drugs.
• The emergence of drug-resistant “super bugs”.
• The pandemic could cause further supply chain disruption.
• The resurgence of coronavirus and the emergence of new infectious diseases.

Outlook

Pandemic-related supply chain disruptions have highlighted the risks associated with South Africa’s overreliance on imported pharmaceutical inputs and certain finished medicinal products, amplifying the need for greater self-sufficiency. Role players have welcomed government’s commitment to support locally manufactured products and are optimistic that local manufacturers will be able to ramp up production to meet the needs of the country and the continent. South African-based pharmaceutical manufacturers are set to benefit from the creation of the African Continental Free Trade Area and, with free trade between African states scheduled to commence in 2021, role players are hoping to expand pharmaceutical exports into the rest of Africa. In the wholesale and retail markets, stakeholders predict that players will continue to explore non-traditional distribution, delivery and dispensing models. Ecommerce is expected to remain on a strong growth trajectory. With private retail pharmacies already partnering with the Department of Health to dispense antiretroviral (ARV) treatment and chronic medications to state-patients, role players anticipate a higher level of collaboration between the public and private sectors going forward. In the research and development space, stakeholders are hopeful of attracting investment for the development of new treatments and hygiene products. In the interim, the quest for safe and effective coronavirus vaccines and other treatments continues. Researchers say that until such time as a reliable vaccine has been administered to the population, hand sanitisers will remain a vital aspect of the pandemic response.

Read More..
The Pharmaceutical Industry in South Africa 2020

Full Report

R 1 900.00(ZAR) estimated $99.18 (USD)*

Industry Landscape

R 1 330.00(ZAR) estimated $ 69.43 (USD)*

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 20 000.00(ZAR) estimated $1044.05 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $339.32 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

Table of Contents

[ Close ]
PAGE
1. INTRODUCTION 1
2. DESCRIPTION OF THE INDUSTRY 1
2.1. Industry Value Chain 7
2.2. Geographic Position 8
3. SIZE OF THE INDUSTRY 9
4. STATE OF THE INDUSTRY 12
4.1. Local 12
4.1.1. Corporate Actions 17
4.1.2. Regulations 18
4.1.3. Enterprise Development and Social Economic Development 24
4.2. Continental 25
4.3. International 28
5. INFLUENCING FACTORS 33
5.1. Coronavirus 33
5.2. Government Interventions 35
5.3. Economic Environment 37
5.4. Labour Resources 39
5.5. Technology, Research and Development (R&D) and Innovation 40
5.6. Environmental Concerns 42
5.7. Drug Abuse 42
5.8. Substandard Products 43
6. COMPETITION 43
6.1. Barriers to Entry 45
7. SWOT ANALYSIS 46
8. OUTLOOK 47
9. INDUSTRY ASSOCIATIONS 48
10. REFERENCES 49
10.1. Publications 49
10.2. Websites 50
APPENDIX 1 52
Summary of Notable Players 52
COMPANY PROFILES 64
ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD 64
ACINO HEALTHCARE GROUP (PTY) LTD 66
ADCOCK INGRAM HOLDINGS LTD 69
AFRICAN MEDICINES (PTY) LTD 74
AFRIPLEX (PTY) LTD 76
AIM AFRICA 79
ALPHA PHARM (PTY) LTD 81
AMKA PRODUCTS (PTY) LTD 83
AMWAY SOUTH AFRICA (PTY) LTD 86
ASCENDIS HEALTH LTD 88
ASPEN PHARMACARE HOLDINGS LTD 94
ASTELLAS PHARMA (PTY) LTD 100
ASTRAZENECA PHARMACEUTICALS (PTY) LTD 102
AUROBINDO PHARMA (PTY) LTD 104
AUSTELL PHARMACEUTICALS (PTY) LTD 106
B BRAUN MEDICAL (PTY) LTD 108
BARRS PHARMACEUTICALS INDUSTRIES (PTY) LTD 111
BAXTER HEALTHCARE SOUTH AFRICA (PTY) LTD 113
BAYER (PTY) LTD 115
BECTON DICKINSON (PTY) LTD 118
BIO EARTH MANUFACTURING (PTY) LTD 120
BIOCLONES (PTY) LTD 122
BIOLOGICALS AND VACCINES INSTITUTE OF SOUTHERN AFRICA (PTY) LTD (THE) 124
BITEK INDUSTRIES (PTY) LTD 126
BRANSON CHEMICALS (PTY) LTD 128
CALIFORNIA PHARMACEUTICALS (PTY) LTD 130
CAPRICHEM (PTY) LTD 132
CHEMICAL CONVERTORS (PTY) LTD 135
CHEMTRON HOLDINGS (PTY) LTD 136
CIPLA MEDPRO SOUTH AFRICA (PTY) LTD 137
COLUMBIA PHARMACEUTICALS (PTY) LTD 141
COMED HEALTH (PTY) LTD 143
DEON SCHOEMAN CC 145
DIS-CHEM PHARMACIES LTD 147
DR REDDY'S LABORATORIES (PTY) LTD 157
DYNACHEM (PTY) LTD 159
ECOLAB (PTY) LTD 161
ELI LILLY (SA) (PTY) LTD 163
EVOHEALTH (PTY) LTD 165
FERRING (PTY) LTD 167
FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD 169
FRESENIUS KABI MANUFACTURING SA (PTY) LTD 172
FRESENIUS KABI SOUTH AFRICA (PTY) LTD 174
G M PHARMACEUTICALS (PTY) LTD 177
GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD 179
GLENMARK PHARMACEUTICALS SOUTH AFRICA (PTY) LTD 182
GULF DRUG COMPANY (PTY) LTD 184
H H DURRHEIM (PTY) LTD 186
HERBA ZONE (PTY) LTD 188
HERBALIFE INTERNATIONAL SOUTH AFRICA LTD 190
HERSOL MANUFACTURING LABORATORIES (PTY) LTD 192
HYMED (PTY) LTD 194
IMBC INVESTMENT (PTY) LTD 196
IMVULA HEALTHCARE LOGISTICS (PTY) LTD 198
INFECTION PROTECTION PRODUCTS (PTY) LTD 200
INGELHEIM PHARMACEUTICALS (PTY) LTD 202
ISZIPHARM PHARMACEUTICAL DISTRIBUTORS (PTY) LTD 204
JOE SOAP CC 206
JOHNSON AND JOHNSON (PTY) LTD 208
KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD 210
KEVALI CHEMICAL GROUP (PTY) LTD 212
LAKATO (PTY) LTD 214
MEDICHEM (PTY) LTD 216
MEGA MAGIC CC 217
MERCK (PTY) LTD 219
MSD (PTY) LTD 221
NATIONAL BIOPRODUCTS INSTITUTE 223
NATIVA (PTY) LTD 225
NEOLIFE INTERNATIONAL (PTY) LTD 227
NESTLE (SOUTH AFRICA) (PTY) LTD 229
NETCARE PHARMACIES (PTY) LTD 233
NETCARE PHARMACIES 2 (PTY) LTD 235
NEW CLICKS SOUTH AFRICA (PTY) LTD 237
NKUNZI PHARMACEUTICALS (PTY) LTD 240
NOVARTIS SOUTH AFRICA (PTY) LTD 242
NUTRITIONAL HOLDINGS LTD 245
OMNIA HOLDINGS LTD 249
P AND G SOUTH AFRICAN TRADING (PTY) LTD 253
PARCEVAL (PTY) LTD 255
PFIZER LABORATORIES (PTY) LTD 257
PHARMA DYNAMICS (PTY) LTD 260
PHARMACEUTICAL ENTERPRISES (PTY) LTD 262
PHARMACY DIRECT (PTY) LTD 264
PHARMAFORCE (PTY) LTD 266
PHARMED PHARMACEUTICALS (PTY) LTD 268
PICK N PAY STORES LTD 271
PLATCHEM (PTY) LTD 275
PRIME CLEANING SUPPLIERS (PTY) LTD 277
RANBAXY (S A) (PTY) LTD 279
RANBAXY PHARMACEUTICALS (PTY) LTD 281
RECKITT BENCKISER PHARMACEUTICALS (PTY) LTD 283
RICHBAY CHEMICALS (PTY) LTD 285
ROCHE PRODUCTS (PTY) LTD 287
S A F I C (PTY) LTD 290
S A NATURAL PRODUCTS (PTY) LTD 292
S BUYS (PTY) LTD 294
SAFARMEX (PTY) LTD 297
SAFETY CHEMICALS (PTY) LTD 299
SANDOZ SOUTH AFRICA (PTY) LTD 300
SANOFI INDUSTRIES SOUTH AFRICA (PTY) LTD 302
SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD 304
SHOPRITE HOLDINGS LTD 307
SISONKE PARTNERSHIP (THE) 312
SOLGAR SOUTH AFRICA (PTY) LTD 314
SONKE PHARMACEUTICALS (PTY) LTD 316
SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE) 318
SPAR GROUP LTD (THE) 322
SPECIALISED MAINTENANCE PRODUCTS (PTY) LTD 328
SPECPHARM HOLDINGS (PTY) LTD 329
SPECTANK (PTY) LTD 331
TEVO (PTY) LTD 333
TIGER BRANDS LTD 335
TOPMED HEALTH CARE DISTRIBUTORS (PTY) LTD 340
TOUCHLESS GERM CONTROL WESTERN CAPE CC 342
TRANSPHARM (PTY) LTD 343
UNILEVER SOUTH AFRICA (PTY) LTD 345
VITAL HEALTH FOODS (PTY) LTD 348
WACO AFRICA (PTY) LTD 350
WELLNESS WAREHOUSE (PTY) LTD 354
WOOLWORTHS HOLDINGS LTD 357
XIXIA PHARMACEUTICALS (PTY) LTD 361

Introduction

This report focuses on the pharmaceutical sector, which researches, develops, markets and distributes drugs, as part of the wider healthcare system. The industry is valued at R50bn at manufacturers’ exit price and R68bn using retail sales. The challenge facing the industry is expanding access to and affordability of drugs, on the one hand and growing South Africa’s drug manufacturing capacity on the other. The sector seeks to meet this challenge in the context of implementation of the National Health Insurance (NHI) and rapid technological developments.

Strengths

• Investments in capabilities to conduct clinical trials, secondary and tertiary manufacturing.
• Many different pharmaceutical companies operating in specialised markets.
• South Africa has a high demand for pharmaceutical products.

Weaknesses

• Dependence on imported active pharmaceutical ingredients and pharmaceuticals.
• Skills shortages remain high, with 12,000 pharmacists needed to meet the international benchmarks.
• Uncertainty over the implementation of National Health Insurance.

Opportunities

• Export into growing markets in Africa.
• Improvements in regulatory environment with the South African Health Products Regulatory Authority offering an improved service.
• Intellectual property landscape supportive of more affordable drugs and local manufacturing.
• Local manufacturing capabilities can be leveraged to serve growing market demand in the rest of Africa and globally.

Threats

• Continued closures of independent pharmacies.
• Debt in larger companies may limit expansion and may result in the closure of units or even entire businesses.
• Increasing regulatory costs.
• Low economic growth and currency volatility.

Outlook

The outlook for the pharmaceutical industry in South Africa is challenging. Since 2017, high debt in major companies has necessitated restructuring and the sale of businesses, and this process is likely to continue. Government support for pharmaceutical manufacturers, price setting for medications and investments in special economic zones represents an opportunity for the growth of local manufacturing capacity, although this is contingent on government and the private sector meeting their commitments. In providing support, government is hoping to grow local manufacture of drugs and bring down the cost of medicines. The changes to the intellectual property regime, vigilance of the Competition Commission and activism in civil society continue to point to a framework that potentially supports a reduction in drug prices and builds local manufacturing capacity.

The Pharmaceutical Industry in South Africa 2019

Full Report

R 1 900.00(ZAR) estimated $99.18 (USD)*

Industry Landscape

R 1 330.00(ZAR) estimated $ 69.43 (USD)*

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 20 000.00(ZAR) estimated $1044.05 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $339.32 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

Table of Contents

[ Close ]
PAGE
1. INTRODUCTION 1
2. DESCRIPTION OF THE INDUSTRY 1
2.1. Industry Supply Chain 4
2.2. Geographic Position 5
3. SIZE OF THE INDUSTRY 5
4. STATE OF THE INDUSTRY 6
4.1. Local 6
4.1.1. Corporate Actions 11
4.1.2. Regulations 12
4.1.3. Enterprise Development and Social Economic Development 14
4.2. Continental 15
4.3. International 15
5. INFLUENCING FACTORS 17
5.1. Economic Environment 17
5.2. Labour Resources 19
5.3. Technology, Research and Development (R&D) and Innovation 22
5.4. Environmental Concerns 22
6. COMPETITION 23
6.1. Barriers to Entry 25
7. SWOT ANALYSIS 25
8. OUTLOOK 26
9. INDUSTRY ASSOCIATIONS 26
10. REFERENCES 27
10.1. Publications 27
10.2. Websites 28
APPENDIX 1 30
Summary of Notable Players 30
COMPANY PROFILES 41
ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD 41
ACINO HEALTHCARE GROUP (PTY) LTD 43
ADCOCK INGRAM HOLDINGS LTD 45
AFRICAN MEDICINES (PTY) LTD 50
AFRIPLEX (PTY) LTD 52
AIM AFRICA 55
ALPHA PHARM (KZN) (PTY) LTD 57
ALPHA PHARM (PTY) LTD 59
ALPHA PHARM EAST CAPE (PTY) LTD 61
AMWAY SOUTH AFRICA (PTY) LTD 63
ASCENDIS HEALTH LTD 66
ASPEN PHARMACARE HOLDINGS LTD 73
ASTELLAS PHARMA (PTY) LTD 79
ASTRAZENECA PHARMACEUTICALS (PTY) LTD 81
AUROBINDO PHARMA (PTY) LTD 83
AUSTELL LABORATORIES (PTY) LTD 85
B BRAUN MEDICAL (PTY) LTD 87
BAXTER HEALTHCARE SOUTH AFRICA (PTY) LTD 90
BAYER (PTY) LTD 92
BECTON DICKINSON (PTY) LTD 95
BIOCLONES (PTY) LTD 97
BIOFORCE SOUTH AFRICA (PTY) LTD 99
CALIFORNIA PHARMACEUTICALS (PTY) LTD 101
CIPLA MEDPRO SOUTH AFRICA (PTY) LTD 103
COLUMBIA PHARMACEUTICALS (PTY) LTD 107
COMED HEALTH (PTY) LTD 109
DEON SCHOEMAN CC 111
DIS-CHEM PHARMACIES LTD 113
DR REDDY'S LABORATORIES (PTY) LTD 122
ELI LILLY (SA) (PTY) LTD 124
FERRING (PTY) LTD 126
FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD 128
FRESENIUS KABI MANUFACTURING SA (PTY) LTD 131
FRESENIUS KABI SOUTH AFRICA (PTY) LTD 133
G M PHARMACEUTICALS (PTY) LTD 136
GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD 138
GULF DRUG COMPANY (PTY) LTD 141
H H DURRHEIM (PTY) LTD 143
HERBA ZONE (PTY) LTD 145
HERBALIFE INTERNATIONAL SOUTH AFRICA LTD 147
HERSOL MANUFACTURING LABORATORIES (PTY) LTD 149
IMBC INVESTMENT (PTY) LTD 151
IMVULA HEALTHCARE LOGISTICS (PTY) LTD 153
INGELHEIM PHARMACEUTICALS (PTY) LTD 156
JOHNSON AND JOHNSON (PTY) LTD 158
KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD 160
LAKATO (PTY) LTD 162
MERCK (PTY) LTD 164
MSD (PTY) LTD 166
NATIONAL BIOPRODUCTS INSTITUTE 168
NATIVA (PTY) LTD 170
NEOLIFE INTERNATIONAL (PTY) LTD 172
NESTLE (SOUTH AFRICA) (PTY) LTD 174
NETCARE PHARMACIES (PTY) LTD 178
NETCARE PHARMACIES 2 (PTY) LTD 180
NEW CLICKS SOUTH AFRICA (PTY) LTD 182
NKUNZI PHARMACEUTICALS (PTY) LTD 185
NOVARTIS SOUTH AFRICA (PTY) LTD 187
NUTRITIONAL HOLDINGS LTD 190
OMNIA HOLDINGS LTD 193
P AND G SOUTH AFRICAN TRADING (PTY) LTD 197
PARCEVAL (PTY) LTD 199
PFIZER LABORATORIES (PTY) LTD 201
PHARMA DYNAMICS (PTY) LTD 204
PHARMACEUTICAL ENTERPRISES (PTY) LTD 206
PHARMACY DIRECT (PTY) LTD 208
PHARMED PHARMACEUTICALS (PTY) LTD 210
PICK N PAY STORES LTD 213
RANBAXY (S A) (PTY) LTD 218
RANBAXY PHARMACEUTICALS (PTY) LTD 220
ROCHE PRODUCTS (PTY) LTD 222
S A NATURAL PRODUCTS (PTY) LTD 225
S BUYS (PTY) LTD 227
SANDOZ SOUTH AFRICA (PTY) LTD 230
SANOFI INDUSTRIES SOUTH AFRICA (PTY) LTD 233
SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD 235
SHOPRITE HOLDINGS LTD 238
SISONKE PARTNERSHIP (THE) 242
SOLGAR SOUTH AFRICA (PTY) LTD 244
SONKE PHARMACEUTICALS (PTY) LTD 246
SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE) 248
SPAR GROUP LTD (THE) 252
SPECPHARM HOLDINGS (PTY) LTD 257
TIGER BRANDS LTD 259
TRANSPHARM (PTY) LTD 264
VITAL HEALTH FOODS (PTY) LTD 266
WELLNESS WAREHOUSE (PTY) LTD 268
XIXIA PHARMACEUTICALS (PTY) LTD 271
ZENITH PHARMACEUTICAL DISTRIBUTORS (PTY) LTD 273

Report Coverage

The detailed report on the Pharmaceutical industry focuses on developments in the South African manufacturing and retail sectors during 2016 and 2017. The report profiles 88 companies including newcomer Inicio, which recently secured a licensing agreement with German firm Fluxpharm. The agreement is a key step towards possible domestic production of active pharmaceutical ingredients (APIs) for HIV/AIDS drugs, which locally-based pharmaceutical manufacturers currently import from China and India. If this is successful, South Africa will have its first black-owned pharmaceutical company. State-owned pharmaceutical manufacturer Ketlaphela has yet to begin production of APIs. Also profiled are three companies that have been investigated by the Competition Commission in relation to the supply of various cancer medicines, Pfizer, Aspen and Roche and its US-based biotechnology company, Genentech.

Introduction

This report focuses on developments in the South African pharmaceutical industry during 2016 and 2017. The pharmaceutical industry provides the vital service of providing medication and was valued at R42.6bn in 2016. The most important challenges facing the industry are tensions between improving access to affordable medicines on the one hand, and growing the manufacturing of pharmaceuticals on the other. Other factors influencing the sector include the introduction of the National Health Insurance (NHI), significant changes in technologies to manufacture drugs and the emergence of the use of cannabis and other alternative healing methods.

Strengths

• Improving levels of local manufacturing capacity.
• Investments in capabilities to conduct clinical trials, secondary and tertiary manufacturing.
• Many different pharmaceutical companies operating in specialised markets.
• South Africa has a high demand for pharmaceutical products.

Weaknesses

• Dependence on imported APIs and pharmaceuticals.
• Single Exit Price (SEP) mechanism means manufacturers are pressurised as far as pricing is concerned.
• Skills shortages remain high, with 12,000 pharmacists needed to meet international benchmarks.

Opportunities

• Export into growing markets in Africa.
• Improvements in regulatory environment with the launch of the South African Health Products Regulatory Authority (SAHPRA).
• Improvements in the Intellectual Property (IP) landscape.
• Local manufacturing capabilities can be leveraged to serve growing market demand in the rest of Africa and globally.
• The establishment of API manufacturing sites.
• The state pharmaceutical company, Ketlaphela, could reduce prices and support research once it is operational.

Threats

• Continued closures of independent pharmacies.
• Increasing regulatory costs.
• Low economic growth and currency volatility.
• The legalisation of cannabis as a natural medication.

Outlook

Growth in the pharmaceutical industry is likely to continue, but at a slower pace than experienced over the last five years. Role players believe that the South African pharmaceutical industry will continue to experience major changes mainly in meeting the objectives of providing affordable drugs and at the same time growing manufacturing capacity. Reaching these objectives will prove difficult because of the low levels of economic growth, with stakeholders expressing concern regarding the impact this will have on government resources in general, and specifically on the implementation of the NHI. The interaction between an organised civil society lobbying for affordable drugs, and an organised established pharmaceutical sector seeking to protect its patent laws, is expected to play a significant role in determining the future of the pharmaceutical industry in South Africa.

Read More..
The Pharmaceutical Industry in South Africa 2017

Full Report

R 1 900.00(ZAR) estimated $99.18 (USD)*

Industry Landscape

R 1 330.00(ZAR) estimated $ 69.43 (USD)*

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 20 000.00(ZAR) estimated $1044.05 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $339.32 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

Table of Contents

[ Close ]
PAGE
1. INTRODUCTION 1
2. DESCRIPTION OF THE INDUSTRY 1
2.1. Industry Value Chain 4
2.2. Geographic Position 5
3. SIZE OF THE INDUSTRY 6
4. STATE OF THE INDUSTRY 17
4.1. Local 17
4.1.1. Corporate Actions 20
4.1.2. Regulations 21
4.1.3. Enterprise Development and Social Economic Development 24
4.2. Continental 25
4.3. International 26
5. INFLUENCING FACTORS 28
5.1. Economic Environment 28
5.2. Labour 29
5.3. Technology, Research and Development (R&D) and Innovation 31
5.4. Environmental Concerns 31
6. COMPETITION 32
6.1. Barriers to Entry 34
7. SWOT ANALYSIS 34
8. OUTLOOK 35
9. INDUSTRY ASSOCIATIONS 36
10. REFERENCES 37
10.1. Publications 37
10.2. Websites 37
COMPANY PROFILES 38
ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD 38
ADCOCK INGRAM HOLDINGS LTD 40
AFRICAN MEDICINES (PTY) LTD 45
AFRIPLEX (PTY) LTD 47
AIM AFRICA 50
ALPHA PHARM (KZN) (PTY) LTD 52
ALPHA PHARM (PTY) LTD 54
ALPHA PHARM EAST CAPE (PTY) LTD 56
AMWAY SOUTH AFRICA (PTY) LTD 58
ASCENDIS HEALTH LTD 60
ASPEN PHARMACARE HOLDINGS LTD 67
ASTELLAS PHARMA (PTY) LTD 72
ASTRAZENECA PHARMACEUTICALS (PTY) LTD 74
AUROBINDO PHARMA (PTY) LTD 76
AUSTELL LABORATORIES (PTY) LTD 78
B BRAUN MEDICAL (PTY) LTD 80
BAXTER HEALTHCARE SOUTH AFRICA (PTY) LTD 83
BAYER (PTY) LTD 85
BECTON DICKINSON (PTY) LTD 88
BIOCLONES (PTY) LTD 90
CALIFORNIA PHARMACEUTICALS (PTY) LTD 92
CIPLA MEDPRO SOUTH AFRICA (PTY) LTD 94
COLUMBIA PHARMACEUTICALS (PTY) LTD 98
COMED HEALTH (PTY) LTD 100
DEON SCHOEMAN CC 102
DIS-CHEM PHARMACIES LTD 104
DR REDDY'S LABORATORIES (PTY) LTD 113
ELI LILLY (SA) (PTY) LTD 115
FERRING (PTY) LTD 117
FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD 119
FRESENIUS KABI MANUFACTURING SA (PTY) LTD 122
FRESENIUS KABI SOUTH AFRICA (PTY) LTD 124
G M PHARMACEUTICALS (PTY) LTD 127
GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD 129
GULF DRUG COMPANY (PTY) LTD 132
H H DURRHEIM (PTY) LTD 134
HERBA ZONE (PTY) LTD 136
HERBALIFE INTERNATIONAL SOUTH AFRICA LTD 138
HERSOL MANUFACTURING LABORATORIES (PTY) LTD 140
IMBC INVESTMENT (PTY) LTD 142
IMVULA HEALTHCARE LOGISTICS (PTY) LTD 144
INGELHEIM PHARMACEUTICALS (PTY) LTD 146
JOHNSON AND JOHNSON (PTY) LTD 148
KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD 151
LAKATO (PTY) LTD 153
LITHA HEALTHCARE GROUP (PTY) LTD 155
MERCK (PTY) LTD 157
MSD (PTY) LTD 159
NATIONAL BIOPRODUCTS INSTITUTE 161
NATIVA (PTY) LTD 163
NEOLIFE INTERNATIONAL (PTY) LTD 165
NESTLE (SOUTH AFRICA) (PTY) LTD 167
NETCARE PHARMACIES 2 (PTY) LTD 171
NEW CLICKS SOUTH AFRICA (PTY) LTD 173
NKUNZI PHARMACEUTICALS (PTY) LTD 176
NOVARTIS SOUTH AFRICA (PTY) LTD 178
NUTRI PHARMA SOLUTIONS (PTY) LTD 180
NUTRITIONAL HOLDINGS LTD 182
OMNIA HOLDINGS LTD 185
PARCEVAL (PTY) LTD 189
PFIZER LABORATORIES (PTY) LTD 191
PHARMA DYNAMICS (PTY) LTD 194
PHARMACEUTICAL ENTERPRISES (PTY) LTD 197
PHARMACY DIRECT (PTY) LTD 199
PHARMED PHARMACEUTICALS (PTY) LTD 201
PICK N PAY STORES LTD 204
PROCTER AND GAMBLE SA (PTY) LTD 209
RANBAXY (SA) (PTY) LTD 211
RANBAXY PHARMACEUTICALS (PTY) LTD 213
ROCHE PRODUCTS (PTY) LTD 215
S A NATURAL PRODUCTS (PTY) LTD 218
S BUYS (PTY) LTD 220
SANDOZ SOUTH AFRICA (PTY) LTD 223
SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD 226
SHOPRITE HOLDINGS LTD 229
SISONKE PARTNERSHIP (THE) 233
SOLGAR SOUTH AFRICA (PTY) LTD 235
SONKE PHARMACEUTICALS (PTY) LTD 237
SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE) 239
SPAR GROUP LTD (THE) 242
SPECPHARM HOLDINGS (PTY) LTD 247
TIGER BRANDS LTD 249
TRANSPHARM (PTY) LTD 254
VITAL HEALTH FOODS (PTY) LTD 256
WELLNESS WAREHOUSE (PTY) LTD 259
XIXIA PHARMACEUTICALS (PTY) LTD 262
ZENITH PHARMACEUTICAL DISTRIBUTORS (PTY) LTD 264
ZENTIVA SOUTH AFRICA (PTY) LTD 266

Report Coverage

The report on the Pharmaceutical industry describes merger and acquisition activity, the latest regulatory developments and discusses factors influencing the success of the sector. The report profiles 90 companies ranging from South Africa’s two largest pharmaceutical manufacturers, Aspen Pharmacare and Adcock Ingram to newcomers to the Top 20, Mylan and Valeant Pharmaceuticals which both have less than 2% share of the market. Also profiled are African Medicines (Pty) Ltd t/a Pakmed Self Medication and GNLD International (Pty) Ltd, companies that use the services of contract manufacturers such as Wrapsa. Large national retailers with in-house pharmacies like Clicks and Pick ‘n Pay, which have proved to be fierce competition to traditional independent and community pharmacies, are also profiled in this report.

Introduction

This report focuses on developments in the South African pharmaceutical industry during 2015 and 2016. This vital industry, which incorporates research and development, manufacture, import, distribution, wholesale and retail of pharmaceutical products, was valued at R39.3bn in 2015, with total counting units reaching 51.9 billion. Although pharmaceutical companies acknowledge that their primary responsibility is to ensure access to affordable healthcare for consumers, some stakeholders, especially those campaigning for a change in the patent laws and in the private healthcare sector, believe companies continue to place large profits before improved health.

Strengths

• Active government support for industrialisation efforts.
• Strong and active civil society organisations focused on improving access to and affordability of drugs.
• There is a strong pharmaceutical R&D and clinical trial sector.
• Well established local industry, with strong international presence.

Weaknesses

• Currently, dependence on MCC and a long registration period for pharmaceutical products.
• Dependence on imported APIs and pharmaceuticals.
• Patent system for drugs consistently challenged due to high cost of pharmaceuticals.
• SEP regulation which does not allow manufacturers to increase prices to adjust for higher input costs.
• Shortage of pharmacists and pharmacist assistants.

Opportunities

• Export into growing markets in Africa.
• Growth of generic sector.
• Improvements in procurement systems for public sector drug provision.
• Improvements in regulatory environment with the imminent launch of the South African Health Products Regulatory Authority.
• R&D, particularly the “Farmer to Pharma grand challenge.”
• Well-functioning state-run pharmaceutical company could reduce prices and potentially support research.

Threats

• Continued closures of independent pharmacies.
• Low economic growth and currency volatility.
• Regulatory costs are high for alternative and complementary medicines.

Outlook

The South African pharmaceutical industry is expected to experience significant changes over the next few years. These changes include the introduction of a new regulator, the South African Health Products Regulatory Authority (SAHPRA), the implementation of the National Health Insurance and continued focus on industrialisation efforts in the pharmaceutical industry. These developments coupled with a strong civil society advocacy for changing the patent laws, are likely to create an environment that is ripe for change. These changes potentially provide South Africa with a basis to grow the pharmaceutical industry and at the same time reduce the costs of drugs. The growth of the generics segment of the market in particular is likely to provide a basis for growing manufacturing capacity, and at the same time increasing access to life-savings drugs. Stakeholders assert, however, that industry and government will need to cooperate on these matters, as the reforms being undertaken are large and carry with them significant challenges.

Read More..
The Pharmaceutical Industry in South Africa 2016

Full Report

R 1 900.00(ZAR) estimated $99.18 (USD)*

Industry Landscape

R 1 330.00(ZAR) estimated $ 69.43 (USD)*

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 20 000.00(ZAR) estimated $1044.05 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $339.32 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

Table of Contents

[ Close ]
PAGE
1. INTRODUCTION 1
2. DESCRIPTION OF THE INDUSTRY 1
2.1. Industry Value Chain 2
2.2. Geographic Position 4
3. SIZE OF THE INDUSTRY 4
4. STATE OF THE INDUSTRY 16
4.1. Local 16
4.1.1. Corporate Actions 18
4.1.2. Regulations 20
4.1.3. Enterprise Development and Social Economic Development 23
4.2. Continental 23
4.3. International 25
5. INFLUENCING FACTORS 27
5.1. Changes to the Regulatory Environment 27
5.2. Economic Environment 27
5.3. Government Initiatives 28
5.4. Technology, Research and Development (R&D) and Innovation 29
5.5. Labour 29
6. COMPETITION 32
6.1. Barriers to Entry 33
7. SWOT ANALYSIS 34
8. OUTLOOK 35
9. INDUSTRY ASSOCIATIONS 35
10. REFERENCES 36
10.1. Publications 36
10.2. Websites 36
APPENDIX 1 38
List of Mergers and Acquisitions in the Global Pharmaceutical Industry in 2015 and 2016 38
COMPANY PROFILES – MANUFACTURE AND WHOLESALE OF PHARMACEUTICALS AND NUTRICEUTICALS 50
ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD 50
ADCOCK INGRAM HOLDINGS LTD 52
AFRICAN MEDICINES (PTY) LTD 57
AFRIPLEX (PTY) LTD 59
AIM AFRICA 62
ALPHA PHARM (KZN) (PTY) LTD 64
ALPHA PHARM (PTY) LTD 66
ALPHA PHARM EAST CAPE (PTY) LTD 68
AMWAY SOUTH AFRICA (PTY) LTD 70
ASCENDIS HEALTH LTD 72
ASPEN PHARMACARE HOLDINGS LTD 78
ASTELLAS PHARMA (PTY) LTD 82
ASTRAZENECA PHARMACEUTICALS (PTY) LTD 84
AUROBINDO PHARMA (PTY) LTD 87
AUSTELL LABORATORIES (PTY) LTD 89
B BRAUN MEDICAL (PTY) LTD 91
BAYER (PTY) LTD 95
BECTON DICKINSON (PTY) LTD 98
BIOCLONES (PTY) LTD 100
CALIFORNIA PHARMACEUTICALS (PTY) LTD 102
CIPLA MEDPRO SOUTH AFRICA (PTY) LTD 104
COLUMBIA PHARMACEUTICALS (PTY) LTD 108
COMED HEALTH (PTY) LTD 110
CREST CHEMICALS (PTY) LTD 112
DB FINE CHEMICALS (PTY) LTD 114
DEON SCHOEMAN CC 116
DIS-CHEM PHARMACIES (PTY) LTD 118
DR REDDY'S LABORATORIES (PTY) LTD 123
ELI LILLY (SA) (PTY) LTD 125
FERRING (PTY) LTD 127
FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD 129
FRESENIUS KABI MANUFACTURING SA (PTY) LTD 132
G M PHARMACEUTICALS (PTY) LTD 134
GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD 136
GNLD INTERNATIONAL (PTY) LTD 138
GULF DRUG COMPANY (PTY) LTD 140
H H DURRHEIM (PTY) LTD 142
HERBA ZONE (PTY) LTD 144
HERBALIFE INTERNATIONAL SOUTH AFRICA LTD 146
HERSOL MANUFACTURING LABORATORIES (PTY) LTD 148
IMBC INVESTMENT (PTY) LTD 150
IMVULA HEALTHCARE LOGISTICS (PTY) LTD 152
INGELHEIM PHARMACEUTICALS (PTY) LTD 155
JOHNSON AND JOHNSON (PTY) LTD 157
KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD 160
LAKATO (PTY) LTD 162
LITHA HEALTHCARE GROUP (PTY) LTD 164
MERCK (PTY) LTD 167
MSD (PTY) LTD 169
NATIONAL BIOPRODUCTS INSTITUTE 171
NATIVA (PTY) LTD 173
NESTLE (SOUTH AFRICA) (PTY) LTD 175
NEW CLICKS SOUTH AFRICA (PTY) LTD 178
NKUNZI PHARMACEUTICALS (PTY) LTD 181
NOVARTIS SOUTH AFRICA (PTY) LTD 183
NUTRI PHARMA SOLUTIONS (PTY) LTD 186
NUTRITIONAL HOLDINGS LTD 188
OMNIA HOLDINGS LTD 191
PARCEVAL (PTY) LTD 195
PFIZER LABORATORIES (PTY) LTD 197
PHARMA DYNAMICS (PTY) LTD 200
PHARMACEUTICAL ENTERPRISES (PTY) LTD 202
PHARMACY DIRECT (PTY) LTD 204
PHARMED PHARMACEUTICALS (PTY) LTD 206
PROCTER AND GAMBLE SA (PTY) LTD 209
RANBAXY (SA) (PTY) LTD 211
ROCHE PRODUCTS (PTY) LTD 213
S A NATURAL PRODUCTS (PTY) LTD 216
S BUYS (PTY) LTD 218
SANDOZ SOUTH AFRICA (PTY) LTD 220
SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD 222
SAVANNAH FINE CHEMICALS (PTY) LTD 224
SHOPRITE HOLDINGS LTD 226
SISONKE PARTNERSHIP (THE) 232
SK CHEMTRADE SERVICES (PTY) LTD 234
SOLGAR SOUTH AFRICA (PTY) LTD 236
SONKE PHARMACEUTICALS (PTY) LTD 238
SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE) 240
SPECPHARM HOLDINGS (PTY) LTD 243
TIGER BRANDS LTD 245
TRANSPHARM (PTY) LTD 250
VITAL HEALTH FOODS (PTY) LTD 252
WARREN CHEM SPECIALITIES (PTY) LTD 255
XIXIA PHARMACEUTICALS (PTY) LTD 257
ZENITH PHARMACEUTICAL DISTRIBUTORS (PTY) LTD 259
ZENTIVA SOUTH AFRICA (PTY) LTD 261
COMPANY PROFILES - RETAIL OF PHARMACEUTICALS 263
AIM AFRICA 263
CLICKS RETAILERS (PTY) LTD 265
DEON SCHOEMAN CC 267
DIS-CHEM PHARMACIES (PTY) LTD 269
G M PHARMACEUTICALS (PTY) LTD 275
NATIVA (PTY) LTD 277
NETCARE PHARMACIES 2 (PTY) LTD 279
NEW CLICKS SOUTH AFRICA (PTY) LTD 281
PICK N PAY STORES LTD 284
SANDOZ SOUTH AFRICA (PTY) LTD 288
SHOPRITE HOLDINGS LTD 290
SPAR GROUP LTD (THE) 296
WELLNESS WAREHOUSE (PTY) LTD 301

Introduction

This report focuses on the South African pharmaceutical industry. The manufacturing industry generated R32.4bn while the retail industry in pharmaceutical and medical goods, cosmetics and toiletries reached R49.96bn in 2013. Generic drug use is increasing rapidly, driven by government’s goal for more affordable pharmaceuticals in South Africa. The domestic manufacturing industry is relatively small and 65% of pharmaceuticals are imported. Medical aids have increasing power, shaping consumer use of pharmaceuticals to the advantage of corporate pharmacies, which have been able to grow their share of the market to 35.5% since 2004.

Strengths

• Pharmaceuticals are a vital part of the healthcare system.
• The two leading pharmaceutical companies are locallybased, generic manufacturers.
• There are a variety of different types of pharmaceutical companies present in the country.
• There is a strong pharmaceutical R&D and clinical trial sector.

Weaknesses

• Critical skill shortage of pharmacists and pharmacist assistants.
• Dependence on imported APIs and pharmaceuticals.
• Dependence on MCC and a long registration period for pharmaceutical products.
• SEP regulation which does not allow manufacturers to increase prices to adjust for higher input costs

Opportunities

• Establishment of SAHPRA which is to replace the MCC.
• Increasing roll-out of government tenders for generic drugs to treat HIV/AIDS and TB.
• NHI through which a large number of South Africans will be given access to pharmaceuticals.
• Opportunities for API and pharmaceutical manufacturing exist.
• Patent expiry opens the market for the development of generics.
• Potential for generic manufacturers to utilise their spare capacity to produce products to export globally.
• Potential for increased exports to African countries.

Threats

• Continuing delays in the registration of pharmaceutical product at the MCC.
• Deteriorating economic conditions.
• For community pharmacists, the practice of DSP.
• Increasing number of cheap imports from India and China.
• New regulations for complementary and alternative medicines will mean high costs which may be prohibitive for small companies.
• Rising input costs, especially rising cost of imported APIs.

Outlook

The growth in the global pharmaceutical industry is expected to be between 3% and 6% CAGR, reaching a value of approximately $1.2 trillion in 2016. For the local industry, growth is expected because of increasing government support for the use and manufacture of pharmaceuticals. The future is “very positive from a generic point of view” according to Vivian Frittelli, CEO of the National Association of Pharmaceutical Manufacturers and the generic manufacturing industry is expected to grow by 10% in 2014 and 10% to 12% annually up to 2019. This is because of government’s increasing support for the use of generics for the treatment of HIV/AIDS and TB and the expiry of the patents for a number of originator drugs. In the short term, however, the deteriorating macroeconomic outlook is likely to slow the consumption of pharmaceuticals in the private healthcare and retail pharmaceutical sector and impact on the costs of imported ingredients and products. Manufacturers are therefore likely to look for opportunities outside South Africa to drive volumes and profits.

The Pharmaceutical Industry in South Africa 2014

Full Report

R 1 900.00(ZAR) estimated $99.18 (USD)*

Industry Landscape

R 1 330.00(ZAR) estimated $ 69.43 (USD)*

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 20 000.00(ZAR) estimated $1044.05 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $339.32 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $99.18 (USD)*

View Report Add to Cart

Table of Contents

[ Close ]
PAGE
1. INTRODUCTION 1
2. DESCRIPTION OF THE INDUSTRY 1
2.1. Industry Supply Chain 2
3. SIZE OF THE INDUSTRY 2
4. STATE OF THE INDUSTRY 17
4.1. Local 17
4.1.1. Manufacture and Distribution/Wholesale 17
4.1.2. Retail 19
4.1.3. Corporate Actions 19
4.1.4. Regulations 20
4.1.5. Black Economic Empowerment 22
4.2. Continental 22
4.3. International 24
5. INFLUENCING FACTORS 24
5.1. SEP 24
5.2. Intellectual Property Law 25
5.3. Slow Registration Process for New Pharmaceuticals 25
5.4. Medical Aids 25
5.5. National Health Insurance (NHI) 26
5.6. Economic Environment 26
5.7. Disease Burden 26
5.8. New regulations for Complementary Medicines 26
5.9. Counterfeit Medicine 26
5.10. Labour Resources 27
5.11. Environmental Concerns 27
6. COMPETITION 28
6.1. Barriers to Entry 28
6.2. Research and Development (R&D) and Innovation 28
7. SWOT ANALYSIS 30
8. OUTLOOK 30
9. INDUSTRY ASSOCIATIONS 31
10. REFERENCES 31
10.1. Publications 31
10.2. Websites 32
ORGANOGRAM 33530 33
Manufacture of Pharmaceuticals and Nutriceuticals 33
COMPANY PROFILES 39
ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD 39
ADCOCK INGRAM HEALTHCARE (PTY) LTD 40
AFRICAN MEDICINES (PTY) LTD 42
AFRIPLEX (PTY) LTD 43
AIM AFRICA INC 44
AMWAY SOUTH AFRICA (PTY) LTD 45
ASCENDIS HEALTH LTD 46
ASPEN PHARMACARE HOLDINGS LTD 48
ASTELLAS PHARMA (PTY) LTD 51
ASTRAZENECA PHARMACEUTICALS (PTY) LTD 52
AUROBINDO PHARMA (PTY) LTD 54
AUSTELL LABORATORIES (PTY) LTD 55
B BRAUN MEDICAL (PTY) LTD 56
BAYER (PTY) LTD 58
BIOCLONES (PTY) LTD 60
CALIFORNIA PHARMACEUTICALS (PTY) LTD 61
CHEMPURE (PTY) LTD 62
CIPLA MEDPRO SOUTH AFRICA (PTY) LTD 63
CLICKS GROUP LTD 66
COLUMBIA PHARMACEUTICALS (PTY) LTD 69
COMED HEALTH (PTY) LTD 70
COVIDIEN (PTY) LTD 72
CREST CHEMICALS (PTY) LTD 73
DB FINE CHEMICALS (PTY) LTD 75
DEON SCHOEMAN CC 76
DIS-CHEM CONSOLIDATED (PTY) LTD 77
DR REDDY'S LABORATORIES (PTY) LTD 78
FERRING (PTY) LTD 79
FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD 80
FRESENIUS KABI MANUFACTURING SA (PTY) LTD 82
GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD 83
GM PHARMACEUTICALS (PTY) LTD 85
GNLD INTERNATIONAL (PTY) LTD 86
GULF DRUG COMPANY (PTY) LTD 87
HERBA ZONE (PTY) LTD 88
HERBALIFE INTERNATIONAL SOUTH AFRICA LTD 89
HERSOL MANUFACTURING LABORATORIES (PTY) LTD 90
INGELHEIM PHARMACEUTICALS (PTY) LTD 91
JOHNSON & JOHNSON (PTY) LTD 92
KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD 94
LITHA HEALTHCARE GROUP LTD 95
MERCK (PTY) LTD 97
MSD (PTY) LTD 98
NATIVA (PTY) LTD 99
NESTLE (SA) (PTY) LTD 100
NKUNZI PHARMACEUTICALS (PTY) LTD 102
NOVARTIS SOUTH AFRICA (PTY) LTD 103
NUTRI PHARMA SOLUTIONS (PTY) LTD 105
NUTRITIONAL HOLDINGS LTD 106
OMNIA HOLDINGS LTD 108
PARCEVAL (PTY) LTD 110
PFIZER LABORATORIES (PTY) LTD 111
PHARMA DYNAMICS (PTY) LTD 113
PHARMA NATURA (PTY) LTD 115
PHARMACEUTICAL ENTERPRISES (PTY) LTD 116
RANBAXY (SA) (PTY) LTD 117
REGAL NUTRIENTS (PTY) LTD 119
ROCHE PRODUCTS (PTY) LTD 120
SA NATURAL PRODUCTS (PTY) LTD 122
SANDOZ SOUTH AFRICA (PTY) LTD 123
SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD 124
SAVANNAH FINE CHEMICALS (PTY) LTD 126
SK CHEMTRADE SERVICES (PTY) LTD 127
SOLGAR SOUTH AFRICA (PTY) LTD 128
SONKE PHARMACEUTICALS (PTY) LTD 129
SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE) 130
SPECPHARM HOLDINGS (PTY) LTD 132
SPORTRON INTERNATIONAL (PTY) LTD 133
SUNRIDER SOUTH AFRICA (PTY) LTD 134
SWISSGARDE (PTY) LTD 135
TIGER BRANDS LTD 136
VITAL HEALTH FOODS (PTY) LTD 139
WARREN CHEM SPECIALITIES (PTY) LTD 141
WINTHROP PHARMACEUTICALS (PTY) LTD 142
ORGANOGRAM 61394A 143
Wholesale of Pharmaceuticals 143
COMPANY PROFILES 145
ALPHA PHARM (KZN) (PTY) LTD 145
ALPHA PHARM EAST CAPE (PTY) LTD 146
ALPHA PHARM WESTERN CAPE LTD 147
BECTON DICKINSON (PTY) LTD 148
CHERYL HAWKINS SOLE PROPRIETOR 152
CLICKS GROUP LTD 153
DIS-CHEM PHARMACIES (PTY) LTD 156
ELI LILLY (SA) (PTY) LTD 159
FREE STATE BUYING ASSOCIATION LTD 160
HH DURRHEIM (PTY) LTD 161
IMBC INVESTMENT (PTY) LTD 163
IMVULA HEALTHCARE LOGISTICS (PTY) LTD 164
LAKATO (PTY) LTD 166
NAMPAK PRODUCTS LTD 167
P&G SOUTH AFRICAN TRADING (PTY) LTD 170
PHARMACY DIRECT (PTY) LTD 171
PHARMED PHARMACEUTICALS (PTY) LTD 172
PREMIER FOODS (PTY) LTD 174
RTT GROUP (PTY) LTD 176
SISONKE PARTNERSHIP (THE) 179
TRANSPHARM (PTY) LTD 181
UTI SOUTH AFRICA (PTY) LTD 182
XIXIA PHARMACEUTICALS (PTY) LTD 185
ZENITH PHARMACEUTICAL DISTRIBUTORS (PTY) LTD 186
ORGANOGRAM 62310A 187
Retail of Pharmaceuticals 187
COMPANY PROFILES 188
CHRONIC MEDICINE DISPENSARY (PTY) LTD 188
CLICKS DIRECT MEDICINES (PTY) LTD 189
CLICKS GROUP LTD 190
DIS-CHEM PHARMACIES (PTY) LTD 193
NETCARE PHARMACIES 2 (PTY) LTD 196
PICK 'N PAY STORES LTD 197
S BUYS (PTY) LTD 220
SHOPRITE HOLDINGS LTD 222
SPAR GROUP LTD (THE) 226
WELLNESS WAREHOUSE (PTY) LTD 229